160 related articles for article (PubMed ID: 18725330)
1. Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures.
Naletova I; Schmalhausen E; Kharitonov A; Katrukha A; Saso L; Caprioli A; Muronetz V
Biochim Biophys Acta; 2008 Dec; 1784(12):2052-8. PubMed ID: 18725330
[TBL] [Abstract][Full Text] [Related]
2. Unfolded, oxidized, and thermoinactivated forms of glyceraldehyde-3-phosphate dehydrogenase interact with the chaperonin GroEL in different ways.
Naletova IN; Muronetz VI; Schmalhausen EV
Biochim Biophys Acta; 2006 Apr; 1764(4):831-8. PubMed ID: 16551514
[TBL] [Abstract][Full Text] [Related]
3. [The non-functioning chaperonin GroEL stimulates protein aggregation].
Naletov IN; Shmal'gauzen EV; Shalova IN; Pleten' AP; Tsiriul'nikov K; Ertl' T; Muronets VI
Biomed Khim; 2006; 52(5):518-24. PubMed ID: 17180927
[TBL] [Abstract][Full Text] [Related]
4. Effect of human neuronal tau on denaturation and reactivation of rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase.
Chen YH; He RQ; Liu Y; Liu Y; Xue ZG
Biochem J; 2000 Oct; 351(Pt 1):233-40. PubMed ID: 10998366
[TBL] [Abstract][Full Text] [Related]
5. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
Gerszon J; Rodacka A
Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
[TBL] [Abstract][Full Text] [Related]
6. Glyceraldehyde-3-phosphate dehydrogenase: Aggregation mechanisms and impact on amyloid neurodegenerative diseases.
Muronetz VI; Barinova KV; Stroylova YY; Semenyuk PI; Schmalhausen EV
Int J Biol Macromol; 2017 Jul; 100():55-66. PubMed ID: 27215901
[TBL] [Abstract][Full Text] [Related]
7. GroEL-assisted dehydrogenase folding mediated by coenzyme is ATP-independent.
Zhang S; Li J; Wang CC
Biochem Biophys Res Commun; 2001 Jul; 285(2):277-82. PubMed ID: 11444838
[TBL] [Abstract][Full Text] [Related]
8. Participation of chaperonin GroEL in the folding of D-glyceraldehyde-3-phosphate dehydrogenase. An approach based on the use of different oligomeric forms of the enzyme immobilized on sepharose.
Bulatnikov IG; Polyakova OV; Asryants RA; Nagradova NK; Muronetz VI
J Protein Chem; 1999 Jan; 18(1):79-87. PubMed ID: 10071932
[TBL] [Abstract][Full Text] [Related]
9. Effects of macromolecular crowding on the unfolding and the refolding of D-glyceraldehyde-3-phosophospate dehydrogenase.
Ren G; Lin Z; Tsou CL; Wang CC
J Protein Chem; 2003 Jul; 22(5):431-9. PubMed ID: 14690245
[TBL] [Abstract][Full Text] [Related]
10. Binding of a burst-phase intermediate formed in the folding of denatured D-glyceraldehyde-3-phosphate dehydrogenase by chaperonin 60 and 8-anilino-1-naphthalenesulphonic acid.
Li XL; Lei XD; Cai H; Li J; Yang SL; Wang CC; Tsou CL
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):505-11. PubMed ID: 9531491
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the interaction site of CP12 with glyceraldehyde-3-phosphate dehydrogenase from Chlamydomonas reinhardtii. Functional consequences for glyceraldehyde-3-phosphate dehydrogenase.
Lebreton S; Andreescu S; Graciet E; Gontero B
FEBS J; 2006 Jul; 273(14):3358-69. PubMed ID: 16803460
[TBL] [Abstract][Full Text] [Related]
12. Misfolded forms of glyceraldehyde-3-phosphate dehydrogenase interact with GroEL and inhibit chaperonin-assisted folding of the wild-type enzyme.
Polyakova OV; Roitel O; Asryants RA; Poliakov AA; Branlant G; Muronetz VI
Protein Sci; 2005 Apr; 14(4):921-8. PubMed ID: 15741339
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to inactive conformations of glyceraldehyde-3-phosphate dehydrogenase inactivate the apo- and holoforms of the enzyme.
Arutiunova EI; Pleten AP; Nagradova NK; Muronetz VI
Biochemistry (Mosc); 2006 Jun; 71(6):685-91. PubMed ID: 16827661
[TBL] [Abstract][Full Text] [Related]
14. A stable cold folding intermediate of rabbit muscle D-glyceraldehyde 3-phosphate dehydrogenase.
Zhang NX; Wang C
Eur J Biochem; 1999 Sep; 264(3):1002-8. PubMed ID: 10491151
[TBL] [Abstract][Full Text] [Related]
15. Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease.
Shalova IN; Cechalova K; Rehakova Z; Dimitrova P; Ognibene E; Caprioli A; Schmalhausen EV; Muronetz VI; Saso L
Biochim Biophys Acta; 2007 May; 1770(5):826-32. PubMed ID: 17324518
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to the nonnative forms of d-glyceraldehyde-3-phosphate dehydrogenase: identification, purification, and influence on the renaturation of the enzyme.
Grigorieva JA; Dainiak MB; Katrukha AG; Muronetz VI
Arch Biochem Biophys; 1999 Sep; 369(2):252-60. PubMed ID: 10486144
[TBL] [Abstract][Full Text] [Related]
17. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease.
El Kadmiri N; Slassi I; El Moutawakil B; Nadifi S; Tadevosyan A; Hachem A; Soukri A
Pathol Biol (Paris); 2014 Dec; 62(6):333-6. PubMed ID: 25246025
[TBL] [Abstract][Full Text] [Related]
18. Assisted folding of D-glyceraldehyde-3-phosphate dehydrogenase by trigger factor.
Huang GC; Li ZY; Zhou JM; Fischer G
Protein Sci; 2000 Jun; 9(6):1254-61. PubMed ID: 10892818
[TBL] [Abstract][Full Text] [Related]
19. "Half of the sites" binding of D-glyceraldehyde-3-phosphate dehydrogenase folding intermediate with GroEL.
Li J; Wang CC
J Biol Chem; 1999 Apr; 274(16):10790-4. PubMed ID: 10196153
[TBL] [Abstract][Full Text] [Related]
20. Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization.
Ni CL; Shi HP; Yu HM; Chang YC; Chen YR
FASEB J; 2011 Apr; 25(4):1390-401. PubMed ID: 21209058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
